A multicenter,open-label,comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis |
| |
Authors: | Stratta R J,Alloway R R,Hodge E,Lo A Pancreas Investigators Vital Outcomes Trial Study Group |
| |
Affiliation: | Department of General Surgery, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157, USA. rstratta@wfubmc.edu |
| |
Abstract: | |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|